Skip to Content

IDEX Corp

IEX: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$175.00GzwggcKyygrqghm

Idex Earnings: Full-Year Outlook Maintained After Solid First Quarter

Narrow-moat-rated Idex posted solid first-quarter results, considering headwinds in the life sciences and analytical instrumentation businesses, as its adjusted EPS of $1.88 came in above management’s guidance range of $1.70 to $1.75. While nothing in the earnings release materially alters our long-term outlook, we’ve sightly raised our fair value estimate to $220 from $219 due to time value of money. We view the name as fairly valued at current levels.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of IEX so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center